Summary. Earlier studies demonstrated that epididymal mouse spermatozoa have a surface-associated factor which inhibits fertilizing ability in a reversible manner. The factor can be removed from uncapacitated spermatozoa by gentle centrifugation, resulting in immediately highly fertile gametes, and it can be added back to capacitated spermatozoa, resulting in poorly fertile cells in which the acrosome reaction has been blocked. Using such inhibition of in-vitro fertilizing ability as an assay, we have carried out experiments to characterize the factor. It appears to be an anionic polypeptide with Mr of approximately 40 000 (according to its behaviour on gel filtration). It is stable to heating at 100\s=deg\C for 15 min and is not destroyed by proteases at pH 8\m=.\0,yet inhibitory activity decreases during sperm incubation in capacitating conditions and is also destroyed in partially purified preparations by endogenous enzyme action during incubation at pH 5\m=.\0. Activity is not adsorbed to either concanavalin A\p=n-\agarose or wheatgerm agglutinin\p=n-\agarose,suggesting that terminal mannose and N-acetylglucosamine residues are not abundant. The factor causes rapid changes in the patterns of chlortetracycline fluorescence seen on sperm heads, a parameter used to assess the capacitated state. Removal of the factor from uncapacitated cells results in a shift to a predominance of capacitated patterns, while the addition of crude or partially purified factor to capacitated cells inhibits the acrosome reaction and causes a shift to the uncapacitated pattern in acrosome-intact spermatozoa. The factor therefore behaves as a decapacitation factor. However, it appears to differ from other characterized decapacitation factors in terms both of molecular size and of abundance of mannose and N-acetylglucosamine residues.
Introduction
At the time of release from the male reproductive tract, mammalian spermatozoa cannot fertilize eggs immediately but acquire such capability during a species-dependent period of residence in the female tract (Austin, 1951; Chang, 1951) . The modifications of the spermatozoon that bring about this functional transformation are termed collectively 'capacitation'; they render the cell able to undergo the acrosome reaction in response to egg-associated factors, and then to penetrate the zona pellucida and fuse with the egg (Yanagimachi, 1988) . The observation by Chang (1957) that the addition of seminal plasma to capacitated rabbit spermatozoa caused a reversible inhibition of fertilizing ability, and the later demonstration by Bedford & Chang (1962) that ultracentrifugation of rabbit seminal plasma sedimented this 'decapacitation factor', initiated studies that have led to the current concept that capacitation involves removal of coating macromolecules from the spermatozoon. Decapacitation, the reversal of capacitation, is brought about by re-application (and hence re-adsorption) of these coating substances to the sperm surface.
Since those early studies, numerous decapacitation factors have been detected in a variety of species; the factors, typically proteins or glycoproteins, have been discussed in detail by Oliphant et al. (1985) . The best characterized are an "acrosome-stabilizing factor" isolated from rabbit seminal plasma (Eng & Oliphant, 1978) and an "antifertility factor" from human seminal plasma (Reddy et al, 1979) . Both of these appear to be large glycoproteins composed of dissimilar subunits (Audhya et al, 1987 ; Wilson & Oliphant, 1987) . As suggested by its name, acrosome-stabilizing factor blocks fertilization by inhibiting the acrosome reaction (Eng & Oliphant, 1978) , whereas current evidence indicates that the antifertility factor from human seminal plasma acts by a different mechanism, as yet unknown (Reddy et al, 1982) .
Previous work (Fraser, 1984) has shown that epididymal mouse spermatozoa have a surfaceassociated component that prevents penetration of the zona pellucida, apparently through inhi¬ bition of the acrosome reaction. The removal of the component, which can be accomplished by gentle centrifugation and resuspension of the spermatozoa in fresh medium, rapidly transforms a poorly fertile suspension into a highly fertile one. Conversely, the addition of the component to capacitated suspensions inhibits their fertilizing ability in a temporary manner: given sufficient time, suspensions become able to fertilize rapidly again. The epididymal component thus appears to behave in general terms as a decapacitation factor. Although other macromolecules may be added to the sperm surface at ejaculation, these latter components do not detectably alter the kinetics of capacitation in vitro: ejaculated spermatozoa recovered from uterine horns shortly after mating and placed into modified Tyrode's medium become capable of rapid fertilization at the same rate as do epididymal spermatozoa (Fraser, 1983b) . The aim of the study reported below was to isolate and characterize the inhibitory epididymal component and to investigate further its mode of action.
A preliminary account of this work has been published in abstract form (Fraser et al, 1989 ).
Materials and Methods
The general materials and methods used for investigating in-vitro fertilization in mice have been described in detail in several previous publications (Fraser, 1983a (Fraser, , b, 1984 and will be given below in outline only.
Preparation of crude inhibitor. Epididymal sperm suspensions were prepared by releasing the contents of each cauda epididymidis from mature male TO mice into a modified Tyrode's medium, lacking pyruvate and lactate but containing glucose, which was supplemented with 0-3 mg bovine serum albumin (BSA; crystalline, from Sigma Chemical Co., Poole, Dorset, UK) per ml; typically, 4 males were used to provide 4 ml suspension. The low level of BSA in the medium as compared with that used for in-vitro fertilization was to facilitate subsequent characterization of the factor.
After 5 min to allow dispersal of spermatozoa, the suspensions were transferred to small, sterile plastic Bijou containers, gassed with 5% C02-5% O2-90% N2, capped, and then incubated at 37°C. Liquid paraffin was not used because it interfered with subsequent chromatography. After 25-30 min, suspensions were centrifuged at 11 600gmax for 4 min; the epididymal supernatants containing the inhibitor were removed, frozen in liquid N2, lyophilized overnight and stored at -20°C.
Partial purification of inhibitor by gel filtration. Lyophilized supernatants were redissolved in 1-2 ml water and centrifuged at 10 000#mai for 4 min at 2°C. The supernatant was then subjected to gel filtration at 2°C on Ultrogel AcA44 (LKB Instruments Ltd, South Croydon, Surrey, UK). The column (0-8 cm2 60 cm) had been freshly equilibrated with 0-4% (w/v) ammonium bicarbonate (51 mM; approximate pH 80); it was eluted with the same medium at 4 ml/h, and 1-5 ml fractions were collected. The absorbance of the eluted fractions was measured at 280 nm; according to the elution profile, the fractions following the BSA peak and including the maximum of the next absorbance peak were pooled (fraction according to Fig. 1 ; see also Fig. 2a and 'Experimental and Results' section relating to gel filtration). The 5 fractions emerging from the column immediately before the first rise in absorbance ('pre-protein' eluate) were also pooled and used for preparing 'blank' samples.
Electrophoresis. Samples of individual fractions from the gel filtration runs or of treated preparations of partially purified inhibitor were subjected to SDS gel electrophoresis, essentially according to Harrison & Gaunt (1988) , using 0-5 mm-thick gradient gels (5-17% w/v). Afterwards, the gels were fixed and stained for protein by a 'silver' method (Morrisey, 1981) .
Preparation of treated inhibitor samples for bioassay. Treated samples were dialysed thoroughly against 100 volumes of freshly prepared 016% (w/v) ammonium bicarbonate (20 mM), using a perturbing roller system (Feinberg, 1976) ; 5 changes of at least 4 h each were made. To reduce losses of inhibitor activity, the dialysis tubing (Visking "8/ 32"; The Scientific Instrument Centre, Eastleigh, Hants, UK) was pretreated with sodium carbonate and ethanol according to Richmond et al (1985) . The dialysed samples were then lyophilized for at least 60 h (to ensure complete removal of ammonium bicarbonate residues).
Bioassay of inhibitor. Sperm suspensions were prepared by releasing the contents of each cauda epididymidis from each of 2 mature TO males into 2 ml modified Tyrode's medium containing BSA at 4 mg/ml. After 5 min to allow spermatozoa to disperse, the suspension was removed and incubated at 37°C under autoclaved liquid paraffin in an atmosphere of 5% C02-5% O2-90% N2 for a further 120 min to ensure complete capacitation (Fraser, 1983a) . The lyophilized samples to be assayed were reconstituted in 0-4 ml medium and used to dilute aliquants of the capacitated sperm suspensions. To In each sample, 100 sperm heads were each classified as having 1 of 3 staining patterns: 'F', with uniform fluor¬ escence over the entire head (characteristic of acrosome-intact uncapacitated spermatozoa); 'B', with a fluorescencefree dark band in the postacrosomal region (characteristic of acrosome-intact capacitated spermatozoa); 'AR', with fluorescence absent from the head (characteristic of acrosome-reacted spermatozoa). The presence or absence of the acrosomal cap was verified in these samples by using phase-contrast illumination (Fraser, 1983b) .
Analysis of data. Data obtained during purification and characterization of the inhibitor were not subjected to statistical analysis. These investigations aimed to detect the relative presence or absence of inhibitor activity in the bioassay, rather than to quantify it precisely. During characterization, the inclusion of'blank' samples (prepared from 'pre-protein' eluate from the gel filtration column) served as internal standards for comparison.
The CTC assessments involving treatment with crude inhibitor, however, were quantitative in nature. These data were analysed using Cochran's modification of the 2x2 contingency tables which allows comparison within and between replicates (Snedecor & Cochran, 1967) .
Experimental Details and Results

Ion-exchange chromatography
In the first series of experiments, lyophilized samples were desalted into lOmM-phosphate pH 80 by passage through Sephadex G-25 (Pharmacia Ltd, Milton Keynes, Bucks, UK) and then applied to a previously equilibrated column (0-8 cm2 6-5 cm) of DEAE-Sepharose CL-6B (Sigma). Material which did not adsorb to the DEAE-Sepharose column was adjusted to pH 60 and applied to a similar column of CM-Sepharose CL-6B (Sigma) previously equilibrated with lOmM-phosphate pH 60. Each column was then eluted with a 'step' of 1 M-NaCl in suitably buffered lOmM-phosphate. Both eluates, as well as the material which did not adsorb to either column, were dialysed against ammonium bicarbonate, lyophilized and then subjected to bioassay. The results (Table la; = 2 replicates) indicated that only material adhering to DEAE-Sepharose possessed inhibitory activity.
In the second series, desalted samples were applied initially to CM-Sepharose at pH 60, and the non-adsorbed material was then applied (after adjustment to pH 80) to DEAE-Sepharose at pH 80. The CM-Sepharose was eluted with a step of 1 M-NaCl as before, but the DEAE-Sepharose was eluted with a gradient of 0-2 M-NaCl in 10 mM-phosphate pH 80. Eluates were monitored for absorbance at 280 nm. All the material from CM-Sepharose was pooled together as a single frac¬ tion, whereas material from DEAE-Sepharose was divided into 3 fractions: that eluting before the main peak of absorbance (assumed to be BSA), that eluting with BSA, and that eluting after BSA. Material that did not adsorb to either column was discarded. Bioassays (Table lb; = 2) indicated that the inhibitory activity was largely in the fraction eluted from the DEAE-Sepharose column after BSA. From these experiments we concluded that the inhibitor is anionic with a high affinity for DEAE-Sepharose. Attempts to develop the use of anion-exchange chromatography to isolate the inhibitor were unsuccessful (data not presented). Bioassay results were inconsistent and losses of activity high; moreover, the positive data we obtained implied that the inhibitor had anionic properties too similar to BSA to allow a ready separation. These studies were therefore not pursued further.
Gel filtration
Lyophilized samples were applied to columns of Ultrogel AcA44 as described in the 'Materials and Methods'. The absorbance profiles of the eluates showed typically 3 identifiable peaks of macromolecular material, the second of these corresponding to BSA (Fig. 1) . Initially, we assayed the material present in each of these peaks plus that in the trough following Peak 3 (Fig. 1 , fraction¬ ation scheme a). Results (Table 2a ; = 5) indicated that, while no inhibitory activity was associ¬ ated with either Peak 1 (fraction i) or the trough following Peak 3 (fraction iv), it was present in Peaks 2 (fraction ii) and 3 (fraction iii). In an attempt to localize more closely the position of the inhibitor, subsequent eluates were divided into 3 fractions: A, front half of Peak 2; B, back half of Peak 2 plus trough plus front half of Peak 3; C, back half of Peak 3 (Fig. 1, fractionation scheme b) . Results (Table 2b; = 5) indicated that the inhibitory activity was most consistently associated with fraction B. As electrophoretic analysis revealed that the material associated with Peak 3 dis¬ played molecular masses of about 27 000 or less (Fig. 1) , the inhibitor's elution position from Ultrogel AcA44, between Peak 3 and BSA, suggests that it has a molecular mass of about 40 000. Further experiments to characterize the inhibitor utilized preparations of fraction as partially purified inhibitor (see 'Materials and Methods'); a representative electropherogram of such a preparation is shown in Fig. 2(a) . Perham (1978) . Aliquants of partially purified inhibitor (in 51 mM-ammonium bicarbonate) were treated for 30 min at 37°C with various levels of guanidine hydrochloride, in the presence or absence of 3 mM-dithiothreitol (final concentration); other aliquants were treated with dithiothreitol alone or were simply incubated at 37°C. Various 'blanks' were similarly treated. At the end of the incubation period, all samples were placed on ice, and, to those samples that had received dithiothreitol, excess iodoacetamide was added to block all exposed thiol groups. After a further 5 min, sufficient 2-mercaptoethanol was added to these samples to block unreacted iodoacetamide. Then all samples were dialysed, lyophilized, and subjected to bioassay. (Fraser, 1984) , we decided that activity was absent if sperm penetration of the zona pellucida had taken place, regardless of whether actual fertilization had occurred. In this way, it was possible to conclude that the inhibitory activity was sensitive to dithiothreitol in the presence of guanidine hydrochloride (Table 5 ; = 4), and therefore that almost certainly the activity resided in a protein of some kind. Chromatography on immobilized lectins The stability of the inhibitor to heat and its resistance to proteolytic attack at pH 8 suggested that its active moiety might involve carbohydrate residues. Accordingly, its affinity for lectins was investigated.
Partially purified inhibitor was applied to concanavalin A-agarose (ConA-ag; BDH, Poole, Dorset, UK) or to wheat-germ agglutinin-agarose (WGA-ag; Pharmacia) at pH 7-5. Each immobilized lectin was in the form of a 1-ml column, and was pre-washed with Hepes-buffered 0-5M-NaCl and a-methylmannoside (ConA-ag) or /V-acetylglucosamine (WGA-ag), before equi¬ libration with 0T2M-NaCl/20mM-Hepes pH 7-5. Samples were cycled through the columns three times to ensure interaction with the lectin, and the columns were then washed thoroughly with Hepes-buffered 0-5M-NaCl; the washings were pooled with the cycled samples, to constitute the 'unbound' fractions. The ConA-ag was then eluted with 0-3 M-a-methylmannoside in Hepesbuffered saline at pH 7-5, while the WGA-ag was eluted with 0-3 M-/V-acetylglucosamine; the eluates constituted the 'bound' fractions. A 'blank' was constructed of equivalent quantities of ammonium bicarbonate, Hepes buffer, NaCl, N-acetylglucosamine and a-methylmannoside.
Bioassays indicated that inhibitory material did not bind detectably to either column (see Table  6 for ConA-ag A data, = 2; WGA-ag data not presented, = 1). It was concluded that the inhibitor did not contain abundant terminal residues of mannose and /V-acetylglucosamine. Two aliquants of partially purified inhibitor were adjusted to pH 50 with 1 M-acetic acid and incubated at 37°C for 6 h; a third aliquant was incubated similarly but without pH adjustment. At the end of the incubation, one of the two aliquants at pH 50 was re-adjusted back to pH 80 with 1 M-Na2C03. All treated samples were then boiled for 10 min. Sub-samples were taken for electro¬ phoretic analysis, after which the main samples were dialysed and lyophilized. Bioassays revealed that incubation at pH 5 0 destroyed inhibitory activity, and electrophoretic analysis showed that such treatment also caused a number of protein components to disappear (Fig. 2) . No changes were observed following incubation at pH 80. It was concluded that an endogenous acid proteinase, only active at acid pH, might be responsible for the destruction of activity.
Effect of inhibitor on chlortetracycline fluorescence patterns in sperm suspensions Sperm suspensions were prepared by releasing the epididymal contents of 2 male mice into 2 ml modified Tyrode's medium containing 4 mg BSA (Sigma) per ml (Fraser, 1983a, b) . After incu¬ bation for 5 min to allow dispersal, 0-6 ml was removed, mixed with 0-3 ml medium and centrifuged at 11 600 #max for 4 min to prepare cell-free supernatant containing the inhibitory factor (similar to the crude inhibitor-containing extract described in the 'Materials and Methods'). The remaining suspension was incubated at 37°C in 5% C02-5% O2-90% N2 for a further 20 min. Then 2 ali¬ quants of 0-3 ml each were removed, mixed with 0-6 ml medium and centrifuged at 600 gmax for Fig. 2 . Changes in partially purified inhibitor preparations during incubation at pH 50. Samples were treated as described below and then boiled for 10 min. Sub-samples were taken and later subjected to SDS gel electrophoresis in the reduced state; the rest of each sample was taken for bioassay. The overall percentage of eggs fertilized by each sample is given, below the relevant electropherogram track (n = 2; > 100 eggs analysed for each sample), (a) Untreated (i.e. kept at 0°C); this pattern is representative of the partially purified inhibitor preparations (pool B, Fig. 1 ) used in characterization studies, (b) Incubated for 6 h at 37°C without pH adjustment (sample in 51 mM-ammonium bicarbonate: approximately pH 80). (c) Incubated for 6 h at 37°C after adjustment to pH 50. (d) Incubated for 6 h at 37°C after adjustment to pH 50, then re-adjusted back to pH 80. 5 min to wash the spermatozoa. Supernatants were removed and pellets were resuspended, one in 0-3 ml fresh medium and one in 0-3 ml inhibitor-containing supernatant. An aliquant from the unwashed suspension served as the control. At 10 min after resuspension, spermatozoa were stained with CTC to assess their capacitation state (see 'Materials and Methods').
The remaining unwashed suspension was incubated for a further 95 min (total of 120 min after release from the epididymides). Two aliquants of 0-2 ml each were removed; one was mixed with 0-2 ml inhibitor-containing supernatant, the other with 0-2 ml fresh medium. After a further 30 min incubation, both were stained with CTC.
Observed patterns of fluorescence over the sperm heads fell into the three categories F, B, and AR, as described by Ward & Storey (1984) ; bright fluorescence was observed in the midpiece region of the tail at all times. Fluorescence patterns in suspensions that had been preincubated for 25 min, washed and then resuspended in inhibitor-containing supernatant did not differ significantly from patterns in unwashed suspensions ( Fig. 3; = 4) (Inh) , and incubated for a further 10 min before being stained with CTC. ***P < 001 compared with unwashed suspensions.
When sperm suspensions were preincubated for 120 min and then incubated for a further 30 min in fresh medium or in inhibitor-containing supernatant, marked differences were again noted between the treatments (Fig. 4; = 6). Significantly more (P < 001) of the cells treated with inhibitor-containing medium displayed the F pattern and significantly fewer displayed the ( < 005) and AR ( < 0025) patterns than did cells incubated with fresh medium. The addition of inhibitor-containing medium to a sperm population, the majority of which were capacitated, therefore inhibited the acrosome reaction and appeared to change the population to one in which the majority of cells with intact acrosomes were uncapacitated. Evidence that the inhibitor itself was responsible for these changes was obtained by treatment of a capacitated sperm population with fractions obtained from gel filtration of crude inhibitorcontaining extract. Gel filtration of lyophilized extracts was carried out on Ultrogel AcA44 as described in the 'Materials and Methods', and the fractions pooled according to fractionation scheme b in Fig. 1 (material eluting before fraction A was also pooled: 'pre-A'). After lyophilization, the pools were coded and randomized. After reconstitution in BSA-supplemented modified Tyrode's medium (described above), the pools were used to dilute sperm suspensions that had been pre-incubated for 120 min ('capacitated'), in a similar fashion to that described above. Control treatments of dilution in crude inhibitor-containing supernatant and in fresh medium were also included. After a further 30 min incubation, all suspensions were stained with CTC. The results (Table 7; = 2) showed that shifts to an uncapacitated state were only observed with fraction B, the fraction known to contain the inhibitor. 
Discussion
As described in the 'Introduction', a previous study (Fraser, 1984) (Ward & Storey, 1984; Neill & Olds-Clarke, 1987) and possibly in man (Lee et al, 1987 (Fig. 4 and (Fraser, 1984) . Nevertheless, it is highly likely that the factor contains a polypeptide chain whose secondary structure is required for inhibition, because dithiothreitol treatment in the presence of guanidine hydrochloride destroyed the activity. Despite its apparent stability at pH 8, the factor was susceptible to degradation by endogenous enzymes when the pH was lowered to 5. Electrophoresis of material incubated under these conditions provided evidence of proteolytic degradation, although other enzymes (such as glycosidases) could have been involved. As mentioned in the 'Introduction', several decapacitation factors have proved to be glycoproteins, and the stability of the mouse factor to heat and to proteinase action at pH 80 might suggest that carbohydrate moieties play an important role in its activity. It was therefore surprising that the factor failed to bind to either concanavalin-A (with high affinity for terminal mannose residues) or wheat-germ agglutinin (with high affinity for /V-acetylglucosamine residues).
In fact, the mouse decapacitation factor appears to have little in common with the best charac¬ terized of the glycoprotein inhibitors. The acrosome-stabilizing factor, purified from rabbit seminal plasma but originating in the epididymis (Thomas et al, 1984) , is composed of dissimilar subunits, with mannose and /V-acetylglucosamine the primary carbohydrate components; it exists predomi¬ nantly as a dimer of Mr 260 000 (Wilson & Oliphant, 1987) . The antifertility factor from human seminal plasma is also a large hetero-dimer of approximate Mr 200 000 containing mannose and Nacetylglucosamine residues; a concanavalin-A column was used during purification ofthe antifertility factor and detectable activity was confined to material adhering to the column (Audhya et al, 1987) . In contrast, the mouse factor did not bind to concanavalin A, and there was no evidence for inhibitory activity associated with material larger than BSA (Mr 67 000), e.g. Table 2 , fraction (i): no inhibition. Shur & Hall (1982) have provided evidence that a mouse epididymal glycoprotein containing repeating /V-acetylglucosamine-galactose residues acts as a decapacitation factor, block¬ ing sperm surface galactosyltransferase acceptor sites needed subsequently for binding to the zona pellucida, and a polylactosamine-containing glycoprotein that inhibits fertilization has been iso¬ lated from mouse epididymal fluid by Müller (1988) . However, there is no evidence that this polylactosamine material inhibits the acrosome reaction; moreover, it has an apparent M, of greater than 106, and contains lectin-bindable /V-acetylglucosamine residues (Müller, 1988) . By several criteria, therefore, the polylactosamine-based decapacitation factor also differs from that of the mouse.
The mechanism of action of the sperm-associated decapacitation factor remains to be elucidated, a task currently hindered by our lack of knowledge regarding the metabolic changes that engender the state of capacitation. Nevertheless (Rufo et al, 1982 (Rufo et al, , 1984 and calsemin in ram and human (Bradley & Forrester, 1982) ; however, neither of these has yet been shown to act as a decapacitation factor and in neither case do the reported characteristics match closely those of our mouse factor. Further studies are clearly merited. Our factor's ability to change a population of cells rapidly from the capacitated to the uncapacitated state indicates a critical role in the complex series of events that clearly comprise capacitation. Elucidation of its effect may well help to resolve the details of this latter process.
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